Technavio, a global technology research and advisory company, projects the global osteosynthesis devices market will experience steady growth from 2016 to 2026.
The four market drivers include:
1. Physician-owned ASCs flooding the market. Surgeons are increasingly performing arthroscopy procedures on an outpatient basis, fueling the demand for physicians owning surgery centers. As surgeons perform more highly advanced MIS procedures, the demand for osteosynthesis devices will follow suit.
2. Increasing demand for bioresorbable devices. These devices are financially beneficial for patients because patients do not need to undergo a follow-up operation to remove osteosynthesis materials.
3. Personalized osteosynthesis products. Technological and product advancements have spurred market growth, as vendors enter the space with a wider range of products sporting different designs to improve surgical clinical outcomes.
4. Augmenting fixation of orthopedic implants with stem cells. Research is underway on combining stem-cell therapies with osteosynthesis devices to improve surgical clinical outcomes.
More articles on devices:
Globus Medical to acquire Alphatec Holdings' international business for $80M — 9 key insights
Paul Thomas newest addition to Cohera Medical's board of directors: 5 highlights
Intellirod Spine raises $1M+ in funding: 5 points